Literature DB >> 3172338

Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual.

K Sakai1, S Dewhurst, X Y Ma, D J Volsky.   

Abstract

A cytopathic human immunodeficiency virus type 1 (HIV-1) isolate containing multiple virus genotypes was molecularly cloned, and the biological activity of six randomly selected clones was assessed by transfection into human lymphoid or glial cell lines. Five infectious clones of HIV-1, termed N1T-A through -E, were isolated in this manner. Clones N1T-A, -B, -C, and -E could be distinguished by restriction endonuclease mapping whereas clones N1T-B and -D had identical maps with the enzymes used. Each clone exhibited a distinct host cell range as well as markedly different infection kinetics and cytopathogenic properties when tested in human cell lines of T-lymphocytic, monocytic, and astrocytic origin. In particular, infection with HIV-1 clone N1T-E was characterized by slow kinetics and lack of significant cytopathic effects in acutely and chronically infected cells. Clone N1T-A, similar to the parental isolate N1T, exhibited a wide host cell range, fast kinetics of infection, and high cytopathogenicity. These data indicate that HIV-infected individuals may carry multiple HIV-1 genotypes with distinct cytopathogenic potential and cell tropism. Analysis of virus isolates must take into account the contribution, or masking, of individual virus clones.

Entities:  

Mesh:

Year:  1988        PMID: 3172338      PMCID: PMC253838     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Differential ability of human immunodeficiency virus isolates to productively infect human cells.

Authors:  L A Evans; T M McHugh; D P Stites; J A Levy
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

3.  Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.

Authors:  B H Hahn; M A Gonda; G M Shaw; M Popovic; J A Hoxie; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  Determinants for the establishment of permanent tissue culture lines from human gliomas.

Authors:  B Westermark; J Pontén; R Hugosson
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-11

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus.

Authors:  K Dahl; K Martin; G Miller
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

7.  Human immunodeficiency virus can productively infect cultured human glial cells.

Authors:  C Cheng-Mayer; J T Rutka; M L Rosenblum; T McHugh; D P Stites; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 8.  Retroviral etiology of the acquired immune deficiency syndrome (AIDS).

Authors:  D J Volsky; K Sakai; M Stevenson; S Dewhurst
Journal:  AIDS Res       Date:  1986-12

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

Authors:  Y Koyanagi; S Miles; R T Mitsuyasu; J E Merrill; H V Vinters; I S Chen
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

View more
  50 in total

1.  Variable sensitivity to substitutions in the N-terminal heptad repeat of Mason-Pfizer monkey virus transmembrane protein.

Authors:  Chisu Song; Eric Hunter
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.

Authors:  S T Perry; M T Flaherty; M J Kelley; D L Clabough; S R Tronick; L Coggins; L Whetter; C R Lengel; F Fuller
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Generation and characterization of the human immunodeficiency virus type 1 mutants.

Authors:  A Adachi; N Ono; H Sakai; K Ogawa; R Shibata; T Kiyomasu; H Masuike; S Ueda
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.

Authors:  S Carpenter; S Alexandersen; M J Long; S Perryman; B Chesebro
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

Authors:  B Odermatt; M Eppler; T P Leist; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

7.  Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual.

Authors:  R S Daniels; M H Smith; A G Fisher
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.

Authors:  R J Grimaila; B A Fuller; P D Rennert; M B Nelson; M L Hammarskjöld; B Potts; M Murray; S D Putney; G Gray
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity.

Authors:  X Y Ma; P Sova; W Chao; D J Volsky
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

Authors:  D J Volsky; M Simm; M Shahabuddin; G Li; W Chao; M J Potash
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.